Dr Sai Madhuri Boppana stands out as a trusted name in medical oncology in Vijayawada, known for blending clinical expertise with genuine compassion. With a patient-first philosophy, she is widely respected for designing personalized cancer treatment strategies that align with each individual’s diagnosis, health status, and life priorities. Her approach emphasizes clarity, ensuring patients and families fully understand their options, expectations, and progress at every stage of care. She has also attained special training in Bone marrow transplantation at HCG-Ramaiah, Bengaluru.
Recognized for her meticulous attention to detail and evidence-based decision making, Dr Sai Madhuri Boppana is committed to delivering therapies that balance effectiveness with quality of life. Patients often value her reassuring communication style, ethical practice, and dedication to holistic support throughout the treatment journey. Through professionalism, empathy, and unwavering commitment, she continues to make a meaningful difference in the lives of patients seeking advanced and reliable cancer care in Vijayawada.
Ex. Associate Prof. of Medical Oncology
Medical oncologist in Vijayawada
10 Years of Experience
For expert consultation and personalized cancer care, visit Dr. Sai Madhuri Boppana, one of the best medical oncologists in Vijayawada, and take the next step towards advanced cancer treatment and support.
Dr. Sai Madhuri Boppana is a highly experienced Oncologist in Vijayawada associated with HCG Cancer Centre, a leading cancer hospital known for advanced oncology care and personalized cancer treatment services.
She specializes in the diagnosis, management, and treatment of various cancers, with expertise in:
As a trusted Medical Oncologist in Vijayawada, Dr. Sai Madhuri is committed to providing evidence-based cancer care with a patient-focused approach.
Conducted a research study on “Hyperkalemia in Elderly Hospitalized Patients” in 2014.
Which Risk Score Performs Better in Febrile Neutropenia – MASCC or CISNE? – International Journal of Medicine and Public Health, 2023; 13(4): 26–33.
Study on Long-Term Quality of Life in Ovarian Cancer Survivors After Treatment – International Journal of Medicine and Public Health, 2023; 13(4): 47–51.
Secured First Place in the AMOI 2019 debate competition on the topic: “R-CHOP vs R-DA EPOCH in Double Hit Lymphoma.”
Member of reputed international oncology organizations, including:
